70 related articles for article (PubMed ID: 1877838)
41. Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
Gore ME; Riches P; MacLennan K; O'Brien M; Moore J; Dadian G; Lorentzos A; Garth R; Moskovic E; Archer D
Br J Cancer; 1992 Aug; 66(2):405-7. PubMed ID: 1503916
[No Abstract] [Full Text] [Related]
42. Haemangioendothelioma of the head and neck.
Cole IE
J Laryngol Otol; 1982 Jun; 96(6):545-8. PubMed ID: 7086272
[No Abstract] [Full Text] [Related]
43. Composite hemangioendothelioma on the neck.
Chen YL; Chen WX; Wang J; Jiang Y
Kaohsiung J Med Sci; 2012 Oct; 28(10):564-5. PubMed ID: 23089324
[No Abstract] [Full Text] [Related]
44. [A case of epithelioid hemangioendothelioma of the liver diagnosed by liver biopsy under laparoscopy and treated with interleukin 2 (IL2)].
Aizawa Y; Watanabe F; Fujise K; Watanabe R; Iemoto Y; Isikawa T; Zeniya M; Toda G
Nihon Shokakibyo Gakkai Zasshi; 1991 Dec; 88(12):2904-9. PubMed ID: 1840114
[No Abstract] [Full Text] [Related]
45. Spindle cell hemangioendothelioma: successful treatment with recombinant interleukin-2.
Setoyama M; Shimada H; Miyazono N; Baba Y; Kanzaki T
Br J Dermatol; 2000 Jun; 142(6):1238-9. PubMed ID: 10848757
[No Abstract] [Full Text] [Related]
46. A case of malignant haemangioendothelioma showing response to interleukin 2 therapy.
Inadomi T; Fujioka A; Suzuki H
Br J Dermatol; 1992 Oct; 127(4):442-3. PubMed ID: 1419766
[No Abstract] [Full Text] [Related]
47. Primary malignant hemangioendothelioma of jejunum.
Prabhu SR; Desai SB; Shirahatti RG
Indian J Gastroenterol; 1992 Oct; 11(4):178-9. PubMed ID: 1398795
[TBL] [Abstract][Full Text] [Related]
48. Reconstitution of interleukin-2.
Lancet; 1990 Aug; 336(8712):445-6. PubMed ID: 1974978
[No Abstract] [Full Text] [Related]
49. Systemic angioendotheliomatosis: a possible disorder of a circulating angiogenic factor.
Person JR
Br J Dermatol; 1977 Mar; 96(3):329-31. PubMed ID: 322694
[No Abstract] [Full Text] [Related]
50. Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.
Velotti F; Tubaro A; Stoppacciaro A; Pettinato A; Morrone S; Bossola P; Napolitano T; Miano L; Ruco L; Piccoli M
Ann Ist Super Sanita; 1990; 26(3-4):411-21. PubMed ID: 2091503
[TBL] [Abstract][Full Text] [Related]
51. Treatment of malignant melanoma with interleukin-2.
Philip PA; Flaherty L
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S32-8. PubMed ID: 9122732
[TBL] [Abstract][Full Text] [Related]
52. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sugitani M; Suzuki Z; Tokita J; Yorimitsu K; Sezai Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1958-61. PubMed ID: 1877838
[TBL] [Abstract][Full Text] [Related]
53. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sezai Y
Nihon Hifuka Gakkai Zasshi; 1991 Aug; 101(9):959-63. PubMed ID: 1942594
[TBL] [Abstract][Full Text] [Related]
54. [A dramatic effect of continuous intra-arterial injected recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma].
Takano M; Suzuki Y; Asai T; Masuzawa M; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):719-25. PubMed ID: 1942580
[TBL] [Abstract][Full Text] [Related]
55. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.
Stewart JA; Belinson JL; Moore AL; Dorighi JA; Grant BW; Haugh LD; Roberts JD; Albertini RJ; Branda RF
Cancer Res; 1990 Oct; 50(19):6302-10. PubMed ID: 2205379
[TBL] [Abstract][Full Text] [Related]
56. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
